Chugai looks to Singapore to aid search for novel antibodies
This article was originally published in Scrip
Executive Summary
Chugai, Roche's Japanese affiliate, will invest a total of around S$200 million ($158.7 million) in antibody research in Singapore over the next five years through a new satellite research facility that it has just opened in the island state.